Rho’s new business segment aims to streamline regulatory approval

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/wavebreakmedia)
(Image: Getty/wavebreakmedia)

Related tags: regulatory approval, regulatory, New drug application, New drug, Investigational new drug, Developmental biology

Rho will expand its services with the addition of its Regulatory Strategy and Submissions business segment.

The full-service contract research organization’s (CRO) new segment will support the company’s goal of helping sponsors plan, develop, and submit marketing applications including new drug applications​ (NDAs), biological license applications (BLAs), and marketing authorization applications (MAAs).

Rob Woolson, an applied statistician, will lead the segment as chief strategist with his experience in US and ex-US regulatory submissions. Woolson told us, “The new segment will help streamline our approach to regulatory submissions by providing an integrated approach that brings regulatory, clinical, non-clinical, CMC, and statistical experts together.”

Kevin Barber will join the segment as the vice president along with 35 staff members.

This new segment will add an integrated approach allowing, regulatory, clinical, nonclinical, and statistical experts to work side-by-side. The team will work to support the approval of therapeutic products and help clients at all stages of development from pre-investigational new drug (IND) through post-approval.

“Rho has a long history of successfully helping sponsors develop and submit marketing applications, and this change will help support our continued growth an excellence in this area,”​ said Woolson. 

Related news

Show more

Related products

show more

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 15-Jul-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

Empowering Clinical Trial Sponsors with Analytics

Empowering Clinical Trial Sponsors with Analytics

PerkinElmer | 14-Jul-2021 | Technical / White Paper

Is your Clinical Data Review creating problems or solving them? Take Control of Your Data. PerkinElmer Informatics Clinical Solutions, powered by Tibco...

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 09-Jun-2021 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

What are the building blocks of DCTs?

What are the building blocks of DCTs?

Medable | 26-Apr-2021 | Technical / White Paper

How to create a seamless experience across eConsent, eCOA and more.

Over the past year, tremendous progress was made toward digitizing and...

Related suppliers

Follow us

Products

View more

Webinars